Literature DB >> 11018204

In vivo uptake of azithromycin in human coronary plaques.

C A Schneider1, H Diedrichs, K D Riedel, T Zimmermann, H W Höpp.   

Abstract

Ten patients with symptomatic coronary artery disease received oral azithromycin for 3 days and underwent directional atherectomy on the third day. Azithromycin was found in all plaque samples with a median concentration of 284 ng/ml (95% confidence interval 163 to 517 ng/ml).

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11018204     DOI： 10.1016/s0002-9149(00)01084-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  3 in total

1.  Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.

Authors:  Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

2.  Delta-glycated hemoglobin: a novel independent risk factor for cardiovascular events in patients without diabetes mellitus.

Authors:  H Diedrichs; R Pfister; Z Clement; J Hagemeister; C A Schneider
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

Review 3.  Antibiotic trials for coronary heart disease.

Authors:  Jeffrey L Anderson; Joseph B Muhlestein
Journal:  Tex Heart Inst J       Date:  2004
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.